Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

Observational Follow-up Extension Study to Evaluate Long-term Safety and Tolerability of Immunizations With AFFITOPE AD02 Applied During AFFiRiS002 and AFF004A in Patients With Alzheimer's Disease

This study examines the long term Safety Follow-up of first patients vaccinated with AD02.

Patients who have received AD02 during AFF002 and AFF004A will be observed.

Inclusion Criteria:

• participation in AFF002 and AFF004A

Exclusion Criteria:

• no vaccination with AD02